Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | GAA | P10253 | 3/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.36 |
| ▸ | IDE | P14735 | 1/20 | 0.36 |
| ▸ | MPI | P34949 | 1/20 | 0.36 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.36 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 4/20 | 0.36 |
| ▸ | GLA | P06280 | 3/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8856454 | 0.80 | ALDH1A1 (0.46) | ALDH1A1SMN1; SMN2MAPTGAANPC1 | |
| SCHEMBL5316204 | 0.75 | ALDH1A1 (0.39) | ALDH1A1SMN1; SMN2MAPTGAANPC1 | |
| SCHEMBL20783635 | 0.75 | ALDH1A1 (0.42) | ALDH1A1SMN1; SMN2MAPTGAANPC1 | |
| SCHEMBL819204 | 0.73 | ALDH1A1 (0.45) | ALDH1A1SMN1; SMN2MAPTGAANPC1 | |
| SCHEMBL15732920 | 0.72 | ALDH1A1 (0.43) | ALDH1A1SMN1; SMN2MAPTGAANPC1 | |
| SCHEMBL27418232 | 0.68 | S100A4 (0.44) | ALDH1A1SMN1; SMN2MAPTGAANPC1 | |
| SCHEMBL4311602 | 0.68 | — | — | |
| SCHEMBL927812 | 0.68 | ALDH1A1 (0.50) | ALDH1A1SMN1; SMN2MAPTGAANPC1 | |
| Biphenyl SCHEMBL5711843 | 0.67 | ALDH1A1 (0.53) | ALDH1A1SMN1; SMN2MAPTKDM4EHPGD | |
| SCHEMBL3275756 | 0.67 | PAX8 (0.44) | ALDH1A1SMN1; SMN2MAPTGAANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119569846-A | HMGB1 protein derivatives for removal of biofilm | 国家儿童医院研究所 | 2025-03-07 | — | — | CN | disclosed |
| CN-118994395-A | VISTA receptor | 皮埃尔法布雷医药公司 | 2024-11-22 | — | — | CN | disclosed |
| CN-118459590-A | Anti-BTN 3A antibodies and their use in the treatment of cancer or infectious disorders | 感应检查疗法公司 | 2024-08-09 | — | — | CN | disclosed |
| CN-118307674-A | Antibody molecules against CD73 and uses thereof | 诺华股份有限公司 | 2024-07-09 | — | — | CN | disclosed |
| CN-111630069-B | Human antibodies to Thomsen-non-velle (Tn) antigen | 勃林格殷格翰国际有限公司 | 2024-05-31 | — | — | CN | disclosed |
| CN-113286819-B | Anti-BTN 3A antibodies and their use in the treatment of cancer or infectious disorders | 感应检查疗法公司 | 2024-05-24 | — | — | CN | disclosed |
| CN-110785187-B | Antibody molecules against CD73 and uses thereof | 诺华股份有限公司 | 2024-04-05 | — | — | CN | disclosed |
| CN-112153987-B | Antibody-drug conjugates and their use for the treatment of cancer | 伊纳泰里斯公司 | 2024-01-09 | — | — | CN | disclosed |
| CN-112236456-B | Novel bispecific PD-1/LAG-3 antibody molecules | 上海药明生物技术有限公司 | 2023-12-22 | — | — | CN | disclosed |
| CN-116675777-A | Multispecific ligand binding molecules comprising complement inhibition domains and uses thereof | 苏州光度生物科技有限公司 | 2023-09-01 | — | — | CN | disclosed |
| CN-116162148-A | Multispecific ligand binding molecules and uses thereof | 苏州光度生物科技有限公司 | 2023-05-26 | — | — | CN | disclosed |
| CN-116059351-A | Agonistic antibodies that bind human CD40 and uses thereof | 塞德斯医疗公司 | 2023-05-05 | — | — | CN | disclosed |
| CN-115803047-A | Recombinant sialidases, sialidase fusion proteins with reduced protease sensitivity and methods of use thereof | 帕利昂制药有限公司 | 2023-03-14 | — | — | CN | disclosed |
| CN-109071665-B | Agonistic antibodies that bind human CD40 and uses thereof | 塞德斯医疗公司 | 2022-11-01 | — | — | CN | disclosed |
| CN-115023439-A | anti-CD 73 antibodies | 西福根有限公司 | 2022-09-06 | — | — | CN | disclosed |
| CN-114630838-A | Novel anti-CD 25 antibodies | 法国国家健康和医学研究院 | 2022-06-14 | — | — | CN | disclosed |
| CN-114302897-A | sialidase-HER 2 antibody fusion proteins and methods of use thereof | 帕利昂制药有限公司 | 2022-04-08 | — | — | CN | disclosed |
| CN-114269937-A | Recombinant sialidases and methods of use thereof | 帕利昂制药有限公司 | 2022-04-01 | — | — | CN | disclosed |
| CN-114258431-A | Recombinant human sialidases, sialidase fusion proteins, and methods of use thereof | 帕利昂制药有限公司 | 2022-03-29 | — | — | CN | disclosed |
| CN-112654394-A | Antibody molecules against complement component 5 and uses thereof | 阿塔盖有限责任公司 | 2021-04-13 | — | — | CN | disclosed |